Fonzo GA
Department of Psychiatry and Behavioral Sciences, The University of Texas at Austin Dell Medical School, Austin, TX, USA.
ArticlePsilocybin
Resetting the hippocampal buffer: a neurocognitive account of psychedelic therapy for anxiety-related psychopathology.
ArticleIbogaine
Ibogaine in the Vet Brain: Changes in Brain Metabolism and Connectivity After Ibogaine Administration in Veterans With Traumatic Brain Injury.
ArticlePsychedelics
Psychedelics do not always enhance cognitive flexibility: The potential role of time-varying effects on reward learning processes.
ArticlePsilocybin
Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.
ArticleKetamine
Age-related moderation of adjunctive psychotherapy and early life stress effects on depression symptom reductions following ketamine treatment: Initial insights from a large, naturalistic sample.
ArticlePsilocybin
Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.
ArticleMDMA
A biopsychosocial model of MDMA-assisted therapy in application: Dyadic One Session Treatment for specific phobia.
ArticlePsilocybin
There's More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression.
ArticlePsilocybin
Psilocybin: From Psychiatric Pariah to Perceived Panacea.
ArticleMDMA
MDMA and MDMA-Assisted Therapy.
ArticlePsychedelics
The mechanistic divide in psychedelic neuroscience: An unbridgeable gap?
ArticlePsilocybin